These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6522920

  • 1. In vitro experience with cefonicid.
    Actor P.
    Rev Infect Dis; 1984; 6 Suppl 4():S783-90. PubMed ID: 6522920
    [Abstract] [Full Text] [Related]

  • 2. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M, Cluzel M, Sirot D, Joly B, Sirot J, Cluzel R.
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL, Jones RN, Thornsberry C.
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 5. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN, Quintiliani R, Nightingale CH.
    Clin Pharm; 1984 Nov; 3(1):23-32. PubMed ID: 6365414
    [Abstract] [Full Text] [Related]

  • 6. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL, Jones RN, Thornsberry C.
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [Abstract] [Full Text] [Related]

  • 7. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM, Patel R, Brumfitt W.
    Drugs Exp Clin Res; 1986 Nov; 12(11):861-9. PubMed ID: 3816503
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of cefonicid compared to other antibiotics against clinical bacterial isolates.
    Verbist L, Verhaegen J.
    Acta Clin Belg; 1990 Nov; 45(2):113-9. PubMed ID: 2164309
    [Abstract] [Full Text] [Related]

  • 9. Cefonicid: a stable beta-lactamase inhibitor.
    Mehta RJ, Newman DJ, Bowie BA, Nash CH, Actor P.
    J Antibiot (Tokyo); 1981 Feb; 34(2):202-5. PubMed ID: 6975269
    [Abstract] [Full Text] [Related]

  • 10. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB, Newman DJ, Actor P.
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.
    Weinstein MP.
    Antimicrob Agents Chemother; 1986 Jul; 30(1):187-8. PubMed ID: 3752979
    [Abstract] [Full Text] [Related]

  • 12. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E, Brogden RN.
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [Abstract] [Full Text] [Related]

  • 13. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
    Tartaglione TA, Polk RE.
    Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
    [Abstract] [Full Text] [Related]

  • 14. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE, Cornere BM, MacCulloch D.
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [Abstract] [Full Text] [Related]

  • 15. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
    Jones RN, Fuchs PC, Sommers HM, Gavan TL, Barry AL, Gerlach EH.
    Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
    [Abstract] [Full Text] [Related]

  • 16. A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
    Uri JV.
    Acta Microbiol Hung; 1987 Apr; 34(1):39-44. PubMed ID: 3630630
    [Abstract] [Full Text] [Related]

  • 17. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 18. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE, Kaye D.
    Pharmacotherapy; 1984 Sep; 4(6):325-33. PubMed ID: 6393074
    [Abstract] [Full Text] [Related]

  • 19. Activity of cephamandole against some gram-negative bacilli and staphylococci.
    Dzierzanowska D, Jakubicz P, Niedźwiecka M, Borowski J.
    Arch Immunol Ther Exp (Warsz); 1980 Sep; 28(3):389-91. PubMed ID: 6969585
    [Abstract] [Full Text] [Related]

  • 20. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM, Lackner TE, Monk JP.
    Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.